Furthermore, galectin-9 knockout mice are more resistant to AML morbidity/mortality while double blockade of PD-1/PD-L1 and TIM-3/galectin-9 as associated with reduced leukemic burden (111). Here, LGALS9 is linked to acute myeloid leukemia.